Meld u aan

Margaret M. Billingsley

Department of Bioengineering

University of Pennsylvania

BIOGRAPHY

Margaret M. Billingsley has not added Biography.

If you are Margaret M. Billingsley and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Biomaterials for vaccine-based cancer immunotherapy.

Journal of controlled release : official journal of the Controlled Release Society Dec, 2018 | Pubmed ID: 30312721

Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.

Journal of controlled release : official journal of the Controlled Release Society Dec, 2019 | Pubmed ID: 31678653

Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.

Nano letters Mar, 2020 | Pubmed ID: 31951421

Engineering precision nanoparticles for drug delivery.

Nature reviews. Drug discovery Feb, 2021 | Pubmed ID: 33277608

Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.

Biomaterials science Feb, 2021 | Pubmed ID: 33404020

Nanomaterials for T-cell cancer immunotherapy.

Nature nanotechnology Jan, 2021 | Pubmed ID: 33437036

Ionizable lipid nanoparticles for in utero mRNA delivery.

Science advances Jan, 2021 | Pubmed ID: 33523869

Delivery technologies for T cell gene editing: Applications in cancer immunotherapy.

EBioMedicine May, 2021 | Pubmed ID: 33910123

One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA.

Journal of the American Chemical Society Aug, 2021 | Pubmed ID: 34324336

Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells.

Nano letters Jan, 2022 | Pubmed ID: 34669421

Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery.

Journal of controlled release : official journal of the Controlled Release Society Jan, 2022 | Pubmed ID: 34742747

Lighting the way to personalized mRNA immune cell therapies.

Science advances Feb, 2022 | Pubmed ID: 35196095

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.

Journal of controlled release : official journal of the Controlled Release Society Jul, 2022 | Pubmed ID: 35569584

Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis.

Nature communications Jan, 2023 | Pubmed ID: 36650129

INSTITUTIONS

University of Pennsylvania

JOVE ARTICLES

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Rakan El-Mayta¹,

Marshall S. Padilla¹,

Margaret M. Billingsley¹,

Xuexiang Han¹,

Michael J. Mitchell¹

¹Department of Bioengineering, University of Pennsylvania

Bioengineering

Privacy

Gebruiksvoorwaarden

Beleid

Neem contact met ons op.

Aanbevelen aan bibliotheek

JoVE Nieuwsbrieven

Onderzoek

JoVE Journal
Methoden Collecties
JoVE Encyclopedia of Experiments
Archiveren

Onderwijs

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Faculteitssite

Auteurs

Overzicht
Publicatieproces
Redactieraad
Omvang en beleid
Collegiale beoordeling
VEELGESTELDE VRAGEN
Verzenden

Bibliothecarissen

Overzicht
Getuigenissen
Abonnementen
Toegang
Middelen
Bibliotheek Adviesraad
VEELGESTELDE VRAGEN

Over JoVE

Overzicht
Leiderschap
Blog
JoVE Help Center
JoVE Sitemap

Margaret M. Billingsley

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Bioengineering

University of Pennsylvania

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Department of Bioengineering